Issue navigation
Volume 40, Issue Supplement_1, January 2025
Combination therapy of chronic kidney disease
Editorial
The era of combination of nephroprotective agents in CKD is there
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i1–i2, https://doi.org/10.1093/ndt/gfae260
Reviews
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i3–i17, https://doi.org/10.1093/ndt/gfae212
Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i18–i28, https://doi.org/10.1093/ndt/gfae211
Mineralocorticoid receptor antagonism for non-diabetic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i29–i36, https://doi.org/10.1093/ndt/gfae241
Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i37–i46, https://doi.org/10.1093/ndt/gfae214
Upcoming drug targets for kidney protective effects in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i47–i58, https://doi.org/10.1093/ndt/gfae216
Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i59–i69, https://doi.org/10.1093/ndt/gfae258
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
Nephrology Dialysis Transplantation, Volume 40, Issue Supplement_1, January 2025, Pages i70–i79, https://doi.org/10.1093/ndt/gfae210
